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a b s t r a c t
To understand the functional role of the peroxisomal membrane channel Pxmp2, mice with a targeted
disruption of the Pxmp2 gene were generated. These mice were viable, grew and bred normally.
However, Pxmp2 / female mice were unable to nurse their pups. Lactating mammary gland epithelium
displayed secretory lipid droplets and milk proteins, but the size of the ductal system was greatly
reduced. Examination of mammary gland development revealed that retarded mammary ductal
outgrowth was due to reduced proliferation of epithelial cells during puberty. Transplantation
experiments established the Pxmp2 / mammary stroma as a tissue responsible for suppression of
epithelial growth. Morphological and biochemical examination conﬁrmed the presence of peroxisomes
in the mammary fat pad adipocytes, and functional Pxmp2 was detected in the stroma of wild-type
mammary glands. Deletion of Pxmp2 led to an elevation in the expression of peroxisomal proteins in the
mammary fat pad but not in liver or kidney of transgenic mice. Lipidomics of Pxmp2 /mammary fat
pad showed a decrease in the content of myristic acid (C14), a principal substrate for protein
myristoylation and a potential peroxisomal β-oxidation product. Analysis of complex lipids revealed a
reduced concentration of a variety of diacylglycerols and phospholipids containing mostly polyunsatu-
rated fatty acids that may be caused by activation of lipid peroxidation. However, an antioxidant-
containing diet did not stimulate mammary epithelial proliferation in Pxmp2 / mice.
The results point to disturbances of lipid metabolism in the mammary fat pad that in turn may result
in abnormal epithelial growth. The work reveals impaired mammary gland development as a new
category of peroxisomal disorders.
& 2014 Elsevier Inc. All rights reserved.
Introduction
An emerging link between breast carcinogenesis and abnorm-
alities in the growth of mammary glands during puberty and
pregnancy underlines the importance of identifying mechanisms
governing development of this organ (Lanigan et al., 2007;
McCready et al., 2010). The mouse mammary gland is a useful
model for investigating these mechanisms (Howlin et al., 2006;
Brisken, 2013) since, like the human gland, it consists of ductal and
alveolar epithelium embedded in mammary stroma. However,
composition of the stroma shows some differences. It consists of
the homogeneous adipose tissue in the mouse while the human
stroma is more enriched by highly vascularized connective tissue
(Hovey and Aimo, 2010). In both human and mouse epithelial
growth comprises ductal elongation, side branching, and devel-
opment of alveoli (McNally and Martin, 2011). Enhanced epithelial
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invasion into mammary stroma starts after initiation of puberty.
After the onset of puberty the epithelial growth depends strictly
on estradiol and progesterone (Neville et al., 2002). In addition,
several other endocrine and paracrine factors are involved in the
regulation of growth and maturation of mammary epithelium
(Howlin et al., 2006; Ciarloni et al., 2007). Studies on developing
postnatal mammary gland have revealed instructive and permis-
sive interactions between mesenchymal and epithelial cells. Thus,
the stromal tissue plays an important regulatory role in epithelial
development and, in addition, provides vital metabolic assistance
to the growing epithelial cells (Landskroner-Eiger et al., 2010).
Peroxisomes are oxidative organelles found in cells of all
eukaryotes. The unique feature of these particles is their role in
the metabolism of amphipathic molecules poorly soluble in water
and in lipids such as fatty acids, some steroids and amino acids
(Antonenkov et al., 2010). The main function of mammalian
peroxisomes is the oxidation of long- and very-long-chain fatty
acids (VLCFA), including branched-chain fatty acids (phytanic acid)
and a side chain of bile acid precursors (di- and trihydroxycopros-
tanoyl-CoA). Accordingly, severe diseases (Zellweger syndrome,
X-linked adrenoleukodystrophy, infantile Refsum's disease, rhizo-
meric chondrodysplasia punctata) are known to be caused by
malfunctions of peroxisomes (Wanders and Waterham, 2006). One
of the causative factors leading to deﬁciency of peroxisomal
function might be restrictions in the transfer of metabolites across
the peroxisomal membrane that would result in general (whole
organism) or local (individual organs) metabolic disturbances
(Antonenkov and Hiltunen, 2012). For instance, X-linked adreno-
leukodystrophy is apparently caused by failure in the transmem-
brane transfer of VLCFA. However, diseases linked to the transfer of
other peroxisomal metabolites have not yet been described.
Pxmp2, known also as PMP22, is an abundant 22 kDa membrane
protein in mammalian peroxisomes. We have recently described
the function of this protein as a transport channel with a pore
diameter of 1.4 nm (Rokka. et al., 2009). The channel conducts small
solutes with a molecular mass up to 500 Da, but is unable to
transfer ‘bulky' compounds such as ATP and some cofactors (NAD/H,
NADP/H, CoA and its acylated derivatives). Phenotypic analysis
revealed a failure of Pxmp2-deﬁcient female mice to nurse their
pups due to severely retarded pubertal development of their
mammary glands. Interestingly, our subsequent tissue transplanta-
tion experiments revealed that the mammary phenotype of
Pxmp2 / mice was caused by abnormalities of the mammary
stroma, and not the epithelium itself. We hypothesized that the
deﬁciency in the function of fat pad peroxisomes in mice lacking
the Pxmp2 channel causes deregulation of lipid homeostasis that in
turn may lead to arrest of epithelial growth. This hypothesis was
supported by lipidomics analysis of mammary fat pad. To our
knowledge this is the ﬁrst study to describe a peroxisomal protein
that is indispensable for normal mammary gland development.
Materials and methods
Animal care and treatment
Mice were kept under germ-free conditions with a 12-h light/dark
cycle and free access to food and water. All animal care and
handling procedures were approved by the National Animal Experi-
ment Board of Finland. The generation of Pxmp2-deﬁcient mice
has been described previously (Rokka. et al., 2009). Brieﬂy, Pxmp2
was disrupted by insertion of a LacZ-PGKneo-cassette into exon 2.
The linearized targeting vector was electroporated into 129/SvJRW4
ES cells and recombinant ES cell clones were used for aggregation
with C57BL6/J morulas. The Pxmp2þ / germline offspring identiﬁed
by RT-PCR analysis of tail-tip genomic DNA, were backcrossed with
C57BL/6J mice for 7 generations. The Pxmp2 / progeny were
produced by mating Pxmp2 / male and Pxmp2þ / female mice.
For dated pregnancies, the female mice were mated and inspected
daily for vaginal plugs. The day after copulation was counted as day
0.5 of pregnancy. Cross-ﬁstening experiments were carried out just
after the birth of pups and whole litters (up to 8 pups) were
transferred.
For in vivo treatment, wild-type 4-months-old female mice were
kept on a laboratory chow containing 0.5% (w/w) phytol (Sigma-
Aldrich) for 12 weeks or 0.5% (w/w) cloﬁbrate (ICN Biochemicals)
for 14 days. To study the effect of antioxidants (Lopez-Erauskin
et al., 2011), C57BL/6J and Pxmp2 / female mice were kept on
AIN76A chow supplied with 1050 IU/kg α-tocopherol (Sigma) and 0.5%
(w/w) α-lipoic acid (Sigma). The antioxidant-containing chow was
prepared by SSniff GmbH (Germany). Additionally, mice received 1.0%
(w/v) N-acetyl-L-cysteine, (Sigma-Aldrich) in drinking water, pH 3.5.
The diet started at 3-weeks-of-age and ended at 10 weeks-of-age
when mice were sacriﬁced. The mice in the control groups were kept
on the same chow, but without added antioxidants.
Transplantation experiments
Three types of transplantations were performed using 3-weeks-old
mice (Brisken et al., 1998). Each transplantation surgery was prepared
using a separate recipient mouse. For whole mammary gland trans-
plantation, the inguinal glands of donor mice were dissected and
placed onto the abdominal wall under the ventral skin of recipient
mice. For transplantation of mammary epithelium, the fat pads of
inguinal glands in recipient mice were cleared. An incision was made
in the cleared fat pad and a piece of mammary tissue of about 1.0 mm
from the nipple region of a donor female was implanted. For fat pad
transplantation the cleared fat pad from an inguinal mammary gland
of a donor female with an inserted piece of the mammary tissue from
another donor mouse were placed onto the abdominal muscle wall
of a recipient mouse. After 9 weeks the transplanted tissues and
endogenous mammary glands were analyzed using whole-mount
preparations.
Mammary gland whole mount
Mammary glands were excised, spread on a glass slide, ﬁxed
for a minimum of 2 h in Carnoy's solution, stained overnight
in carmine alum stain, and were permanently mounted with
Permount (Electron Microscopy Sciences). The ductal lengths were
determined by measuring the distance from the nipple area to the
leading edge of the ductal tree. The number of branches was
counted in the whole mammary gland.
Histology and electron microscopy (EM)
Mammary glands were ﬁxed in 4% (w/v) paraformaldehyde,
embedded in parafﬁn and the sections (5.0 μm thick) were stained
with hematoxylin-eosin (H&E). Frozen sections of inguinal mammary
glands were used for Oil red O staining. For transmission EM, tissue
samples were ﬁxed in 2.5% (w/v) glutaraldehyde, postﬁxed in 1.0%
(w/v) osmium-tetroxide, dehydrated in acetone and embedded in
Epon Embed 812 (Electron Microscopy Science). To reveal peroxidase
activity of catalase, tissue slices were incubated in alkaline DAB
medium [0.1% (w/v) 3030-diaminobenzidine tetrahydrochloride (DAB,
Sigma), 5.0% sucrose, and 0.02% (v/v) H2O2 in 50 mM Tris–HCl buffer,
pH 7.6], and postﬁxed in 1% (w/v) osmium tetroxide (Hand, 1973).
Immunohistochemistry
Parafﬁn sections (5.0 μm) of mammary glands were incubated in
Antigen Unmasking Solution (Vector Laboratories). Sections were
M.H. Vapola et al. / Developmental Biology 391 (2014) 66–80 67
then treated with 50% (v/v) methanol containing 1.0% (v/v) H2O2 to
eliminate any endogenous peroxidase. For detection of whey acidic
protein (WAP) and β-casein, the sections were incubated overnight
at 4 1C with goat anti-WAP antibody (sc-14832, Santa Cruz Biotech)
or with goat anti-β-casein antibody (sc-17971, Santa Cruz Biotech),
respectively. A Vectastain ABC Elite kit (Vector Laboratories) was
used for detection of antibodies. For detection of cell proliferation
mice were injected with BrdU (100 μg/g body weight, Sigma-
Aldrich) 2 h before sacriﬁce. Parafﬁn sections (5.0 mm) of mammary
glands were rehydrated and antigen retrieval was conducted using
3.0 mM citrate buffer, pH 6.0. After treatment with 3.0% (v/v) H2O2
to remove endogenous peroxidase activity, the sections were
incubated with rat monoclonal anti-BrdU antibody (OBT 0030G,
AbD Serotec) overnight at 4 1C. A similar procedure was applied for
pro-apoptotic protein activated caspase-3 using rabbit anti-human
caspase-3 antibody (#9661, Cell Signaling Technology). The propor-
tion of BrdU-positive cells was determined as the number of brown
stained mammary epithelial cells divided by the total number of
mammary epithelial cells.
X-Gal staining
Tissue samples were incubated with a ﬁxative solution [0.2%
(v/v) glutaraldehyde, 2.0 mM MgCl2 in 100 mM potassium phos-
phate buffer, pH 7.3] for 2 h, rinsed in washing buffer [0.01% (w/v)
sodium deoxycholate, 0.02% (v/v) NP-40, 2.0 mM MgCl2 in
100 mM potassium phosphate buffer, pH 7.3], and stained over-
night with X-Gal buffer [1.0 mg/ml X-Gal (Sigma-Aldrich), 10 mM
K4Fe(CN)6, 10 mM K3Fe(CN)6, 0.01% (w/v) sodium deoxycholate,
0.02% (v/v) NP-40, 2.0 mM MgCl2 in 100 mM potassium phosphate
buffer, pH 7.3]. After rinsing with washing buffer the samples were
processed for H&E staining.
Hormone analysis
Blood was collected using retro-orbital bleeding. Serum pro-
gesterone was detected by an automated chemiluminescence
system (Advia Centaur, Bayer Corporation) and estradiol was
analyzed by a radioimmunoassay technique (Orion Diagnostic).
Serum and urine biochemical measurements
Mice were weighed and then anesthetized by intraperitoneal
administration (10 μg/g body weight) of a mixture of 0.7% (w/v)
Ketalar (Pﬁzer) and 0.004% (w/v) Domitor (Orion Pharma). Blood
was collected using a retroorbital bleeding technique with sub-
sequent euthanasia by cervical dislocation and harvesting of the
bile and tissues. For urine collection, mice were placed in meta-
bolic cages (model 3700M021, Tecniplast), and samples collected
within 24 h. Serum total protein, cholesterol, bilirubin, triacylgly-
cerols, creatinine, and uric acid and urinary total protein, creati-
nine, and uric acid as well as serum and urinary sodium,
potassium and chloride ions were measured on a Cobas Integra
700 automatic analyzer (Hoffman-LaRoche).
Detection of fatty acids, bile acid derivatives, complex lipids and
polyamines
Serum fatty acids were extracted and detected as described
(Savolainen et al., 2004). Samples from 5-weeks-old female mice
were used for analysis of the total fatty acids and complex lipids in
the mammary fat pad tissue. Mice of this age still contain only a
rudimentary ductal system that allows removal of the fat pad
samples without any admixture of mammary epithelium. In
addition, the metabolic effects of the estrous cycle are expected
to be minimal in mice at this age (Cohen et al., 2002). For analysis
of the total fatty acids the fat pad samples were homogenized in
methanol/chloroform (6:1, v/v). The resulting homogenate was
centrifuged, 1.4 ml aliquots of supernatant were mixed with 1.6 ml
chloroform and 0.4 ml water, and 20 ml of 2.5 mM nonadecanoic
acid methylester (Sigma-Aldrich) was added as an internal stan-
dard. After mixing and centrifugation, 1.5 ml of the lower phase
was evaporated to dryness under a stream of nitrogen at 60 1C. The
residue was re-dissolved in 2.0 ml of 1.0 M HCl in methanol. After
heating for 3 h at 75 1C, the resulting fatty acid methylesters were
extracted twice with hexane and the combined extracts were
evaporated. The residue was re-dissolved in 100 μl hexane,
applied on a silica TLC plates (Merck), and developed using
hexane/ethanol (7:3, v/v). Areas of the TLC plates containing fatty
acid methylesters were visualized with iodine, the esters were
extracted using ethanol and the extracts were evaporated. The
residues were re-dissolved in 20 μl dichloroethane and 1.0 μl of
this solution was used for GLC analysis. Each sample was mea-
sured twice using a Hewlett Packard 5890 gas chromatograph;
ﬁrst, with a Phenomenex Zebron capillary glc column ZB-1701
(Phenomenex) and then with a FS-FFAP-CB-0.25 column (CS-
Chromatographie Service). Bile acid derivatives from serum were
determined as described (Savolainen et al., 2004).
Detection of complex lipids in the mammary fat pads was
performed by ZORA Biosciences. Tissue samples were homoge-
nized in ice-cold 70% (v/v) methanol containing 1.0% (w/v) butyl-
hydroxy-toluene. Lipids were extracted according to a modiﬁed
Folch method (Ekroos, 2008) performed using a Hamilton Micro-
lab Star robot (Jung et al., 2011). Samples were spiked with non-
endogenous synthetic internal standards of known amounts and
after lipid extraction were reconstituted in chloroform/methanol
(1:2, v/v). Synthetic external standards were post-extract spiked to
the extracts before mass-spectrometric analysis. Diacylglycerols,
glycerophospholipids, and sphingomyelins were analyzed by shot-
gun analysis on a hybrid triple quadruple/linear ion trap mass
spectrometer (QTRAP 5500, AB SCIEX) equipped with a robotic
nanoﬂow ion source (NanoMate HD, Advion Biosciences). The
analyses were performed in both positive and negative ion modes
using a multiple precursor ion-scanning and neutral loss based
method (Ekroos et al., 2003). The mass-spectrometry data were
processed using LipidViewTM to produce a list of lipid names and
peak areas. A stringent cutoff was applied to separate background
noise from actual lipid peaks. Lipids were normalized to their
respective internal standard and to sample amount to retrieve
their concentrations. A lipid was included in the analysis if it was
detected at least in 4 samples in both groups.
Polyamines were quantiﬁed using an HPLC technique essen-
tially as described (Pirinen et al., 2007). For sample preparation,
mammary glands or pellets of red blood cells were homogenized
in 25 mM Tris–HCl buffer, pH 7.4 containing 0.1 mM EDTA and
1.0 mM DTT. Proteins were precipitated with 5.0% (v/v) sulfosa-
licylic acid and the supernatant was analyzed. 10 μm diamino-
heptane (Sigma-Aldrich) was used as an internal standard.
Cell fractionation
Samples of fat pad tissue were collected from inguinal mam-
mary glands and homogenates were prepared as described
(Antonenkov et al., 2004). Nuclear and cell debris were removed
by centrifugation at 800g for 10 min. The total membrane fraction
was isolated by centrifugation of the resulting supernatant at
100 000g for 1 h. The sediment was re-suspended in a small
volume of isolation medium, loaded onto a linear 20–40% (v/v)
Optiprep gradient (total volume 11 ml) and centrifuged at
100 000g for 2 h. Fractions of 1.0 ml were collected.
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Electrophysiological measurements
Single-channel analysis of Pxmp2 was conducted essentially as
described (Rokka. et al., 2009). For measurements of reversal
potential a two-fold (1.0 M KCl trans/0.5 M KCl cis compartment)
salt gradient was established after insertion of a single channel
into a stable lipid bilayer. Membrane proteins were solubilized in
0.5% (w/v) Genapol X-080 (Fluka).
Reverse transcription and quantitative RT-PCR analysis
Total RNA was isolated from mammary fat pad, liver or kidney of
individual mice (four mice per group) using an RNeasy Lipid Tissue
Mini Kit (Qiagen). The cDNA equivalent of 3.0 mg RNA was produced
using a RevertAid First Strand cDNA Synthesis Kit (Fermentas).
Quantitative RT-PCR was performed with a 7500 Real Time PCR
System (Applied Biosystems) according to the manufacturer's instruc-
tions. Expression levels of genes for peroxisomal proteins: urate
oxidase (Uox, sequence accession number: NM_008993); xanthine
oxidoreductase (Xor, XM_192827); 70 kDa peroxisomal membrane
protein (Pmp70, NM_008991); catalase (Cat, NM_009804); carnitine
acetyltransferase (Crat, NM_007760); straight- and branched-chain
fatty acid oxidases (Acox1, NM_015729 and Acox2, NM_053115,
respectively); multifunctional enzymes 1 and 2 (MFE1, AK004867
and MFE2, NM_008292, respectively), and polyamine oxidase (Paox,
NM_153783) were detected. For relative quantiﬁcation of gene expres-
sion, the results were normalized to the 18S rRNA or β actin levels.
SDS-PAGE and Western blotting
Tissue homogenates (20%, w/v) were prepared in 20 mM
phosphate buffer, pH 7.4 and centrifuged at 800g for 10 min to
eliminate cellular debris. Proteins were separated by SDS-PAGE
under reducing conditions using 15% (w/v) acrylamide gels
(Criterion Precast Gel, Bio-Rad) and electroblotted onto nitrocel-
lulose ﬁlters (0.45 mm Protran, Schlechter&Schuell). The ﬁlters
were stained with speciﬁc antibodies against estrogen receptor α
(ERα, H-184) than stripped of these antibodies and stained with
anti-β-actin antibodies (sc-1616, Santa Cruz Biotechnology). MCF
whole cell lysate was used in the same experiments as a positive
control (Santa Cruz Biotechnology). Antibody prepared in rabbits
against a synthetic peptide corresponding to the N-terminus of
mouse Pxmp2 (NH2-APAASRLRVESELG) was also used. The loca-
tions of the primary antibodies were visualized using alkaline
phosphatase-labeled anti-rabbit IgG (Pxmp2 antibodies, Sigma-
Aldrich) or the ECL chemiluminescence kit (other antibodies,
Amersham).
Other methods
Thiobarbituric acid-reactive substances (TBA-RS) and the con-
tent of sulfhydryl groups were detected as described (Fernandes
et al., 2010). The activity of marker enzymes and protein content
were determined as described previously (Rokka. et al., 2009).
Statistical analysis
All values are expressed as mean7standard deviation (SD).
The data were analyzed by Student's t test (two-tailed). P-values
less than 0.05 were considered signiﬁcant. In case of complex lipid
detection procedure the normality was not assumed because of
low sample size and the analysis was performed using a non-
parametric two group comparison—Wilcoxon matched pairs test.
Results
General phenotype of Pxmp2-deﬁcient mice
To generate Pxmp2-deﬁcient mice the LacZ-PGKneo-cassette
was selectively inserted into exon 2 of Pxmp2 using homologous
recombination in mouse stem cells (see Rokka. et al., 2009 for
details). Breeding of heterozygous (Pxmp2þ /) mice gave wild-
type, heterozygous, and homozygous (Pxmp2 /) progeny at the
expected Mendelian frequency. Overall, we did not detect any
major alterations in the phenotype of Pxmp2 / animals with the
exception of retarded development of the mammary glands in
female mice (see below). There were no identiﬁed abnormalities in
gross appearance, gait or physical activity of Pxmp2-deﬁcient
mice. The body weights and the weight and appearance of organs
(brain, heart, kidney, liver, and spleen) from Pxmp2 / mice were
similar to those of wild-type animals. Histological analysis (H&E
staining) did not reveal any signiﬁcant alterations in the major
tissues examined. Liver function was normal, as indicated by GOT,
GPT, and bilirubin serum levels. During EM examination of
different tissues we noted ﬂattening and fusion of podocyte
foot processes in kidney of Pxmp2 / mice, while liver and heart
cells showed normal morphology (data not shown). A variety
of biochemical parameters were tested in blood and urine
(Supplementary Table S1). The only difference observed was an
elevated level of uric acid in the blood of Pxmp2 / mice.
Peroxisomes contain polyamine oxidase (Wu et al., 2003), an
enzyme involved in the maintenance of steady-state concentra-
tions of polyamines – putrescine, spermidine, and spermine –
which are regulators of cell growth and differentiation (Moinard
et al., 2005). Measurement of polyamine levels in erythrocytes and
mammary glands of 5 weeks-old females did not reveal substan-
tial differences between groups of Pxmp2-deﬁcient and wild-type
mice with the exception of statistically signiﬁcant changes in the
content of spermine (Supplementary Fig. S1).
Pxmp2-deﬁcient female mice produce pups but are unable
to nurse them
Pxmp2-deﬁcient mice showed normal fertility and produced full-
term litters. The number, sex distribution, and weight of fetuses, as
well as the average litter size, and the weight of newborn pups were
indistinguishable between Pxmp2 / and wild-type mice (data not
shown). However, it was apparent that the Pxmp2 / dams were
able to nurse only very few pups. The Pxmp2 / dams exhibited
normal nursing behavior immediately after parturition, but all the
pups regardless of their genotype failed to thrive and most of them
died within 24 h post partum, despite repeated suckling attempts
(Supplementary Fig. S2A and B). Cross-fostering experiments showed
that when the pups of Pxmp2 / females were foster-nursed by
wild-type dams immediately after their birth, most of them survived.
In contrast, none of the pups born to wild-type females were found
alive 24 h after being transferred to Pxmp2-deﬁcient foster dams
(Supplementary Fig. S2C). These results indicate a possible failure in
lactation of nursing Pxmp2 / female mice. However, we did not
ﬁnd any abnormalities in the nursing of pups by heterozygous,
Pxmp2þ / female mice (data not shown).
Mammary glands of Pxmp2-deﬁcient mice are underdeveloped but
produce milk
To identify the cause of the lactation defect, we ﬁrst analyzed
histological samples obtained at lactation day one. In Pxmp2 /
dams the mammary gland epithelium was poorly developed
and consisted only of a ductal rudiment (Fig. 1A and B). This
was conﬁrmed by detection of the total protein content per g of
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mammary gland tissue (Fig. 1K). In a normal lactating mammary
gland the fat pad is completely ﬁlled with epithelium, highly
enriched with milk proteins, and thus, the protein values obtained
reﬂect the relative amount of epithelium in the gland. Although
mammary gland growth in Pxmp2 / females was deﬁcient, the
rudimental ductal tree showed lobuloalveolar development,
although the alveolar density was substantially decreased
(Fig. 1A–D). Nevertheless, lipid droplets could be observed in the
mammary epithelial cells of Pxmp2-deﬁcient mice (Fig. 1E and F).
The ability of Pxmp2 / mammary epithelium to produce milk
was conﬁrmed by detection of two key protein components of the
milk, β-casein and WAP (Fig. 1G and H) as well as milk fat (Fig. 1I)
in the mammary gland sections. These data were further con-
ﬁrmed by EM examination of the epithelial cells (Fig. 1J). However,
detailed analysis of milk content was not carried out because
milking of Pxmp2 / females post partum was unsuccessful.
Fig. 1. Analysis of mammary gland development and function on lactation day 1. (A and B) Whole-mount preparation of inguinal glands from wild-type (A) and Pxmp2-
deﬁcient (B) mice, scale bar: 1 mm. (C–F) H&E stained sections of mammary glands fromwild-type (C and E) and Pxmp2 / (D and F) mice at low (C and D) and high (E and
F) resolution, scale bars: 500 μm (C and D) and 50 μm (E and F). (G and H) Immunohistological staining of Pxmp2 / mammary glands for milk proteins: β-casein (G) and
WAP (H), scale bars: 500 μm (G) and 100 μm (H). (I) Oil Red O staining for milk fat, bar: 20 μm. (J) EM of mammary gland epithelium from Pxmp2 / mice. L—lipid droplets;
C—casein micelles, bar: 2000 nm. Each experimental group (A–J) contained 3–4 mice. (K) Protein content of the inguinal glands; nPo0.005, n¼12 glands for each group. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 2. Age-dependence of mammary gland development. Left panels: wild-type mice, right panels: Pxmp2-deﬁcient mice. Age of mice (in weeks, WK) or date of pregnancy
(dps) are shown on the left side of panels. (A–J) Whole mount micrographs of inguinal glands were prepared at the following developmental steps: 2 weeks (WK) after birth
(A and B), 5 weeks (C and D), 8 weeks (E and F), 12 weeks (G and H), and 12.5 days (12.5 dpc) of pregnancy (I and J) at the same magniﬁcation, bar: 1.0 mm. (K and L) Whole
mount preparations demonstrate reduced alveolar density and deﬁciency in the number of branching points in the inguinal glands of Pxmp2 / mice (L) relative to wild-
type females (K) at 15.5 days of pregnancy, bar: 1.0 mm. (M and N) Pubertal mouse (5 week old) inguinal glands showing individual mammary ducts that terminate in
undeveloped terminal end buds in Pxmp2 / mice (N), arrows indicate the well-developed terminal end buds in mammary glands of wild-type mice at the same age (M),
bar: 1.0 mm. (O) Number of branching points and (P) an average length of ducts in inguinal mammary glands of females at different ages. At least three mice of each
genotype were analyzed; nPo0.05, nnPo0.002.
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Age-dependence of mammary gland development
To assess whether or not a defect in the growth of mammary
epitheliumwas speciﬁcally linked to a certain time-point of mouse
maturation we analyzed mammary glands of Pxmp2 / mice at
critical developmental stages using a whole-mount technique
(Fig. 2). Importantly, no differences in the morphology of inguinal
mammary glands could be observed at the age of 2 weeks (Fig. 2A
and B), demonstrating that embryonic and pre-pubertal develop-
ment of mammary glands proceeded similarly in wild-type and
Pxmp2 / mice. After the onset of puberty, as veriﬁed by detection
of a vaginal opening (at the age of 2371 and 2372 days in wild-
type [n¼31] and Pxmp2 / [n¼23] mice, respectively), appear-
ance of terminal end buds (TEBs) was analyzed in the mammary
epithelium. In wild-type mice TEBs were detected at 5 weeks of
age (Fig. 2C, E and M) and, consequently, ductal elongation
proceeded until the epithelia ﬁlled the entire stroma by the age
of 12 weeks (Fig. 2C, E, G, O and P). In contrast, no TEBs were
formed in the mammary glands of Pxmp2 / mice and the
mammary epithelial tree remained as a ductal rudiment and failed
to ﬁll the mammary fat pad (Fig. 2D, F, H, N, O and P). During
pregnancy, despite signiﬁcant growth retardation, the ductal
system of Pxmp2 / mammary glands showed side branching
and alveologenesis (Fig. 2I–L). To assess the possibility of estradiol
and progesterone causing the Pxmp2-dependent phenotype we
measured the levels of these hormones in serum of mice at
different ages (Supplementary Table S2). No difference were
observed between the age-matched groups of Pxmp2 / and
wild-type animals, indicating no effects on estradiol and proges-
terone levels in Pxmp2 / mice, caused e.g. by hypothalamic-
pituitary and/or ovarian aberrations. Taken together, our results
indicate that Pxmp2 has no systemic effects on sexual maturation,
but it is indispensable for mammary ductal growth during pub-
erty. However, the terminal differentiation of the existing epithe-
lial cells in the rudimentary glands is not affected. Contrary to
Pxmp2 / female mice, we did not ﬁnd a marked retardation in
the epithelial growth of the heterozygous, Pxmp2þ / , mice
(Supplementary Fig. S3).
Pxmp2 deﬁciency affects proliferation of mammary gland epithelium
The inability of the ductal tree to grow in Pxmp2-deﬁcient
mammary glands may be a result of an insufﬁcient proliferation of
epithelial cells and/or increased apoptosis. Therefore, we analyzed
the proliferative and apoptotic indices of the inguinal mammary
glands of 5-weeks-old mice by BrdU incorporation and immuno-
histochemistry for activated caspase 3, respectively. On average,
16% of the cells in the epithelium of wild-type mammary glands
were in S phase, whereas in Pxmp2 / glands, only 1.0% of the
cells incorporated BrdU (Fig. 3 and Supplementary Fig. S4).
In contrast, caspase 3 immunostaining showed no difference
between genotypes (data not shown) indicating that the growth
defect does not depend on increased apoptosis but, instead, results
from defective proliferation.
The fat pad is responsible for deﬁcient proliferation of mammary
gland epithelium
By using tissue transplantation experiments we aimed to reveal
whether the factors affecting development of Pxmp2 / mam-
mary glands were either of: (i) systemic (other than estradiol and
progesterone), (ii) epithelial or (iii) stromal origin. Transfer of
Fig. 3. Epithelial proliferation in mammary glands. Histological sections of mammary glands from wild-type (A) and Pxmp2 / (B) mice stained with an anti-BrdU antibody,
bar: 200 μm. (C) The relative numbers of BrdU-positive mammary epithelial cells, at least 5000 cells were counted in each group; nPo0.05, n¼4 mice per group.
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Fig. 4. Mammary gland reconstitution experiments. Results (whole mount) of the transplantation of whole mammary glands (A), epithelium (B) or epithelium and fat pad
(D) to recipient mice are presented; bars: 1.0 mm. All grafts that have been produced in reconstitution experiments are shown. Diagrams of transplantation experiments are
also shown. Genotype of mice and transplants is marked as: þ/þ , wild-type; / , Pxmp2-deﬁcient. (B) Three groups of mice with different genotype were analyzed: 1—
wild-type donor epithelium/wild-type recipient mouse; 2—Pxmp2 / donor epithelium/wild-type recipient mouse; 3—wild-type donor epithelium/Pxmp2-deﬁcient
recipient mouse. (C) Total area of epithelial outgrowth (in arbitrary units, AU) after transplantation of epithelium (B, panels 1–3). nPo0.001 if compared with control
transplantations (B1). (D) Groups of mice according to genotype in the reconstitution experiments: 1—wild-type donor epithelium/wild-type donor fat pad/wild-type
recipient mouse; 2—Pxmp2 / donor epithelium/wild-type donor fat pad/Pxmp2 / recipient mouse; 3—wild-type donor epithelium/ Pxmp2 / fat pad/wild-type recipient
mouse. (E) Total number of branching points was analyzed in grafts shown on (D). nPo0.01 if compared with control transplantations (D1).
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whole mammary glands from wild-type and Pxmp2-deﬁcient
donor mice into wild-type recipient mice showed development
of wild-type but failure with Pxmp2 / donor tissue (Fig. 4A—the
ﬁgure shows the results of all executed transplantation experi-
ments). Minor necrotic transformations were detected as a result
of transplantation experiments, however these changes did not
prevent growth of the donor mammary glands as can be seen
using the wild-type transplants (Fig. 4A). Whole mammary gland
transplantation experiments ruled out a systemic factor(s), caused
by Pxmp2 deﬁciency as the source of the observed mammary
phenotype, but instead pointed to a local, tissue level defect in the
mammary gland. Next, we determined whether the growth defect
was of paracrine nature originating from the mammary stroma, or
whether it was caused by autocrine stimuli in the epithelial
compartment itself. A small piece of mammary epithelium from
a Pxmp2 / or wild-type female was transplanted into the fat pad
of 3-week-old virgin mice, cleared from its own epithelium
(Fig. 4B, panels 1–3). In this type of experiments the necrotic
changes were only barely detectable. The transplantations allow
the donor epithelium to penetrate the host fat pad and become
associated with the recipient stroma. Results showed that the
Pxmp2 / epithelium was able to fully elongate when it was
inside a wild-type mammary fat pad (Fig. 4B, panels 2). In contrast,
transplantation of wild-type epithelium into a Pxmp2 / fat pad
resulted only in a rudimentary ductal tree, which failed to ﬁll the
surrounding normal fat pad (Fig. 4B, panels 3). These data were
conﬁrmed by quantitative estimation of the total area of epithelial
outgrowth after transplantation (Fig. 4C). Results of the transplan-
tation experiments using as donor tissues the whole mammary
gland (Fig. 4A) and the mammary epithelium (Fig. 4B and C) are
Fig. 4. (continued)
M.H. Vapola et al. / Developmental Biology 391 (2014) 66–8074
sufﬁcient to conclude that the deﬁcient development of the
Pxmp2 / epithelium is not caused by a defect in the epithelial
cells per se but, instead, is associated with abnormalities in the
mammary stroma. Finally, to conﬁrm further a direct involvement
of the Pxmp2 / fat pad in preventing normal growth of the
mammary epithelium, we transplanted the cleared fat pad to a
donor female mouse together with an inserted piece of epithelium
from another donor mouse into a recipient mouse (Fig. 4D and E).
In ﬁve out of seven control transplantations (wild-type transplants
and recipients; Fig. 4D, panels 1) an intensive epithelial outgrowth
was detected. However, the growth was limited by the area of fat
pad transplanted. The growth was also registered when Pxmp2 /
epithelium was inserted into wild-type donor fat pad and trans-
planted into the Pxmp2-deﬁcient mice (Fig. 4, panels 2). Epithelial
growth was signiﬁcantly reduced only if the epithelium was
transplanted into a cleared Pxmp2 / fat pad in a wild-type
Fig. 5. Detection of peroxisomes and Pxmp2 in fat pad of mammary glands. (A) Electron micrograph of adipocyte stained with DAB to reveal localization of catalase in
peroxisomes. Ps—peroxisomes, L—lipid droplet; bar: 1.0 mm. (B) β-Gal staining of Pxmp2 / fat pad. Dotted staining marked as Gal indicates presence of Pxmp2 protein in the
fat pad adipocytes; bar: 20 μm. (C) Control β-Gal staining of wild-type adipocytes. (D) Fad pad homogenates from 2 mice of each genotype were subjected to SDS/PAGE
followed by Western blotting with antibodies against Pxmp2. (E) Detection of catalase and Pxmp2 proteins in cytosol and total membrane fraction of fat pad homogenate.
(F) Linear Optiprep gradient of total membranes showing co-localization of catalase and Pxmp2. Upper panel: relative activity of catalase, the enzyme recovery was 102%;
lower panel: proteins from equal volumes of each fraction were separated by SDS/PAGE and analyzed by immunoblotting using antibodies against Pxmp2. (G and H)
Electrophysiological analysis of the ‘Pxmp2-like’ channel detected in fractions enriched with fat pad peroxisomes (fractions 4, 9, and 10, see panel F). In all experiments 1.0 M
KCl was used as an electrolyte. (G) Current trace of two channels registered at þ20 mV. (H) Voltage-dependent gating of the channel. Insertion of a single channel (marked
by asterisk) was registered at þ10 mV and the voltage was then increased manually up to þ110 mV with 10 mV intervals. The lower trace shows a timescale-expanded
current record from the upper trace. Note spontaneous three-step closing of the channel (marked by arrows).
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female recipient (Fig. 4D, panels 3 and Fig. 4E). Taken together,
these experiments conﬁrmed that the Pxmp2 / fat pad is solely
responsible for defective development of the mammary epithelium.
Retarded mammary epithelial outgrowth due to Pxmp2 deﬁ-
ciency is reminiscent of the phenotype of ERα knock-out mice
(Mallepell et al., 2006). However, only the epithelial receptor is
required for proliferation and morphogenesis in the mammary
gland which is in contrast with an involvement of the stromal
Pxmp2 protein in the same processes. We did not ﬁnd any
substantial difference in the ERα gene expression in fat pad (data
not shown) or in the level of this protein in whole mammary gland
or fat pad (Supplementary Fig. S4E and F) of wild-type and
Pxmp2 / mice.
Detection of peroxisomes and Pxmp2 in mammary fat pad
The mammary stroma of mice consists mainly of adipocytes
(Landskroner-Eiger et al., 2010). Information about the presence of
peroxisomes in these cells is lacking. Therefore, we examined
samples using EM to determine whether peroxisomes could
be identiﬁed in the adipocytes of mammary fat pad (Fig. 5A
and Supplementary Fig. S5A). We observed small (diameter
0.2–0.3 μm), DAB-positive round or oval particles surrounded by
a single membrane, which are characteristic of peroxisomes. Next,
we investigated the presence and localization of Pxmp2 in fat pad
cells. Several tissues from Pxmp2-deﬁcient mice were stained for
β-gal activity as the LacΖ reporter gene coding for β-gal is a part of
LacΖ-PGKneo-cassette inserted into exon 2 of the Pxmp2 to disrupt
this gene. Speciﬁc staining for β-gal was detected in heart, kidney
(Supplementary Fig. S5B), liver (data not shown), and in the
mammary fat pad adipocytes (Fig. 5B) of Pxmp2 / mice but
was not observed in samples from wild-type animals (Fig. 5C). This
indicates that the Pxmp2 gene is expressed in the tissues analyzed.
These data corroborate with the observation that the Pxmp2 gene
is expressed in a wide range of different tissues analyzed with the
highest level of expression in organs deeply involved in lipid
metabolism, such as liver, heart, white and brown adipose tissues
(V. Tillander and S.E.H. Alexson, personal communication). The
presence of the Pxmp2 protein in mammary fat pad homogenates
from wild-type mice was conﬁrmed by Western blotting (Fig. 5C).
Analysis of the subcellular localization of Pxmp2 revealed that, as
expected, the protein is bound to membranes (Fig. 5D) and shares
a pattern of distribution in an Optiprep gradient with the marker
peroxisomal enzyme catalase (Fig. 5E and Supplementary Fig.
S5C). These data indicate that Pxmp2 is a peroxisomal membrane
protein in fat pad tissue. To detect the activity of stromal Pxmp2 as
a functional membrane channel, proteins from gradient fractions
enriched with peroxisomes were solubilized with detergent and
subjected to electrophysiological analysis using the planar lipid
bilayer technique. We took advantage of the single channel
analysis to study the electrophysiological properties of only one
channel molecule that allows the discrimination of different
channel types in membrane preparations. Using this approach
we identiﬁed channel-forming activity (Fig. 5Fand G) with con-
ductance (1.3470.04 nS slope conductance, 1.0 M KCl, n¼5),
cation selectivity (Erev¼6.7 mV, PK/ClE2.3) and voltage depen-
dence (three-step closure at voltages over 7100 mV) very similar
to those registered for the high-conductance form of a puriﬁed
native Pxmp2 (Rokka. et al., 2009) indicating that fat pad Pxmp2 is
active as a membrane channel.
Effect of Pxmp2 deﬁciency on lipid homeostasis
We hypothesized that deletion of the Pxmp2 channel affects
metabolic processes in peroxisomes by preventing free movement
of small solutes across the peroxisomal membrane. This could lead
to disturbances in synthesis and degradation of metabolites in
peroxisomes from different tissues including mammary fat pad
and eventually results in negative nutritional or regulatory effects
on the developing mammary epithelium. Because mammalian
peroxisomes are heavily involved in lipid metabolism (Wanders
and Waterham, 2006; Antonenkov et al., 2010), we focused on the
comparative analysis of the content of different lipids in body
ﬂuids and in mammary fat pad of wild-type and Pxmp2-deﬁcient
mice. We ﬁrst analyzed the concentration of free fatty acids in
serum (Supplementary Table S3) and the content of bile acids in
bile ﬂuid (Supplementary Table S4). The data did not show any
signiﬁcant differences between the groups indicating that deletion
of Pxmp2 may not result in systemic changes in lipid metabolism
in the whole organism under normal conditions. To investigate the
phenotype of Pxmp2-deﬁcient mice under dietary stress, animals
were fed diets containing phytol, a natural methyl-branched acyl
alcohol metabolized via α-oxidation only in peroxisomes
(Wanders and Waterham, 2006) or cloﬁbrate, a known proliferator
of rodent liver and kidney peroxisomes (Reddy and Hashimoto,
2001). No weight gain or loss and no signiﬁcant alterations in the
morphological appearance of different tissues were detected in
Pxmp2 / mice compared with wild-type animals consuming the
same diet. Similarly, no difference was observed when fatty acids,
including phytol metabolites: phytanic and pristanic acids were
analyzed in serum (Supplementary Table S5). Consumption of
cloﬁbrate led to similar elevation in size and number of peroxi-
somes in liver and kidney of Pxmp2 / and wild-type mice (data
not shown).
In contrast, Pxmp2 deﬁciency led to local disturbances in the
content of total fatty acids and the composition of complex lipids in
the mammary fat pad. In particular, a two-fold decrease in the
concentration of medium-chain myristic acid (C14:0) was registered
(Fig. 6A and Supplementary Table S6). The fatty acid composition of
complex lipids was affected as well (Fig. 6B and Supplementary
Table S7). The hallmark observation was that the levels of a variety
of diacylglycerols, phosphocholines, and phosphoethanolamines
were decreased in the fat pad of Pxmp2 / mice versus wild-type
animals (Fig. 6B). Interestingly, the rate of the decrease was almost
linearly dependent on the number of double bonds in the fatty acids
of diacylglycerols (Fig. 6C). This indicates that the registered
changes in lipid concentrations are highly selective and does not
result from a decrease in the total lipid content of fat pad cells. The
latter was conﬁrmed by analysis of the content of phospholipids
depending on their fatty acid composition. As in the case of
diacylglycerols, the fat pad phospholipids of Pxmp2-deﬁcient mice
contained much less polyunsaturated fatty acids compared to those
of wild-type animals (Fig. 6D).
The data indicating disturbances in fat pad lipid homeostasis of
Pxmp2 / mice were strengthened by gene expression analysis of
some peroxisomal proteins (Fig. 6E and Supplementary Fig. S6).
The reason for this analysis was a well-known ability of mamma-
lian cells to regenerate function of metabolically compromised
peroxisomes by activation of the synthesis of key peroxisomal
enzymes (Reddy and Hashimoto, 2001). Pxmp2 deﬁciency evi-
dently affected the mRNA level of several peroxisomal proteins in
the fat pad (Fig. 6E). Thus, the real time PCR analysis revealed an
elevated content of mRNA for multifunctional enzyme 1, catalase,
and acyl-CoA oxidase 1 in the Pxmp2-deﬁcient versus wild-type
mice. An elevated expression of peroxisomal proteins due to
Pxmp2 deﬁciency is a tissue-speciﬁc event since no differences
were registered in liver and kidney of Pxmp2 / mice relative to
wild-type animals (Supplementary Fig. S6).
Defective metabolism in microperoxisomes, especially in lipid-
rich tissues like myelin, due to malfunctioning of the peroxisomal
membrane transporter ABCD1 that causes the neurodegene-
rative inherited disease X-adrenoleukodystrophy is accompanied
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by oxidative damage from lipid peroxidation (Singh and Pujol,
2010). Similarly, deletion of a single allele of the Pex11β gene
coding for peroxisomal membrane protein Pex11 was sufﬁcient to
trigger oxidative stress and neuronal death in mouse brain
(Ahlemeyer et al., 2012). Furthermore, a diet enriched with
antioxidants reversed signs of neurodegeneration caused by
ABCD1 deﬁciency (Lopez-Erauskin et al., 2011) indicating that
oxidative stress may be a major disease-driving factor in the
pathogenesis of X-adrenoleukodystrophy. Our results showing a
decrease in the amount of polyunsaturated fatty acids in complex
lipids, especially in phosphatidylserine (Tyurina et al., 2008) may
indicate activation of lipid peroxidation in the fat pad of Pxmp2 /
mice. This information led to analysis of the content of oxidative
stress markers – TBA-RS and sulfhydryl groups – in the homo-
genates of mammary fat pad. We also tested whether a diet
enriched with antioxidants would stimulate epithelial growth in
mammary glands of transgenic mice. Detection of the oxidative
stress indicators did not reveal a drastic difference between
control and experimental groups of animals although the content
of sulfhydryl groups was moderately decreased in the mammary
fat pad of Pxmp2 / mice (Supplementary Fig. S7A). In experi-
ments with the antioxidant diet we did not observe any improve-
ments in the development of mammary epithelium in transgenic
mice (Supplementary Fig. S7B–D). Therefore, even when lipid
peroxidation is activated in the Pxmp2 / fat pad, this process
seems to have little effect on epithelial development.
Fig. 6. Effect of Pxmp2 deﬁciency on the lipid content and the expression levels of selected peroxisomal genes in the mammary fat pad. Mammary fat pad of 5-week-old
mice was used for analysis of lipids. (A) Total fatty acids content in mammary fat pad of wild-type (dark grey bars) and Pxmp2 / (light grey bars) mice; n¼5 in each group;
nPo0.05, nnPo0.01. Myristic acid is marked as 14:0. (B) Analysis of complex lipids in mammary fat pad of wild-type (dark gray bars) and Pxmp2 / (light gray bars) mice;
n¼4–6. Only data showing a statistically signiﬁcant difference between the analyzed groups are presented: Po0.05 (not marked) or Po0.01 (marked by an asterisk). The
whole set of results is in Supplementary Table S7. Wilcoxon matched pairs test was used for statistical analysis of the data. DAG, diacylglycerol; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PE-O, alkyl-phosphatidylethanolamine; PS, phosphatidylserine. (C) Dependence between the decrease of DAG’s concentration and the number of
double bonds in fatty acid residues of corresponding DAG’s in the Pxmp2 / mammary fat pad relative to control (wild-type) samples. Note near linear correlation of these
parameters. DAG’s containing fatty acids of different length but with equal number of double bonds per molecule were combined in the corresponding groups. (D) Change in
the phospholipid content in the fat pad of Pxmp2 / relative to wild-type mice depending on the total amount of double bonds in fatty acids. All detected phospholipids in
each class (see Supplementary Table S7) were separated into two groups: containing up to 3 double bonds (dark grey bars) and 4 or more double bonds (light grey bars).
Length of fatty acids was not considered. The average deviation was calculated for each group; nPo0.05, n¼5–8. (E) Expression levels of genes in mammary fat pad of
5-week-old Pxmp2 / mice (light grey bars) compared to those for wild-type control (dark grey bars) were analyzed by quantitative real-time PCR. Data are means7SD of
4–6 mice per group; nPo0.02, nnPo0.05. Mfe1, multifunctional enzyme 1; Mfe2, multifunctional enzyme 2; Acox1, acyl-CoA oxidase; Acox2, pristanoyl-CoA oxidase; Cat,
catalase; Pmp70, peroxisomal 70 kDa membrane protein; Pao, polyamine oxidase.
M.H. Vapola et al. / Developmental Biology 391 (2014) 66–80 77
Discussion
Mammary gland development is a target of intensive research due
to the importance of this organ in reproductive biology and the
tremendous burden of mammary gland neoplasms among life threa-
tening human diseases (Lanigan et al., 2007; McCready et al., 2010).
Growth of mammary epithelium is connected to sexual development
and includes embryonic, prepubertal and pubertal stages, as well as
terminal differentiation during pregnancy, and lactation. More than
ﬁfty different genetically modiﬁed mouse lines have been created that
display aberrant mammary gland development. Most of the identiﬁed
factors regulating mammary growth are linked to endocrine status,
stromal-epithelial cross talk and local signaling. The present work
demonstrates that a deﬁciency in peroxisomal function, through
generation of Pxmp2 null mutant mice, results in failed mammary
epithelial growth during puberty thus adding a novel category –
peroxisomal metabolism – to the list of biological processes essential
for normal development of mammary gland.
The transport network of the peroxisomal membrane represents a
unique biological entity consisting of both, pore-forming channels
carrying ‘small' solutes and transporters speciﬁc for certain ‘bulky’
solutes (Antonenkov and Hiltunen, 2012). Pxmp2 encodes a peroxiso-
mal membrane protein that forms a water-ﬁlled pore with an
estimated diameter of 1.4 nm (Rokka. et al., 2009) connecting the
cytoplasm and the peroxisomal matrix. This channel is non-selective, i.
e. it allows solutes with molecular masses up to 500 Da to diffuse
across the peroxisomal membrane. Indeed, our in vitro experiments on
peroxisomes isolated from the liver of Pxmp2-deﬁcient mice revealed
compromised transfer of solutes across the peroxisomal membrane
(Rokka. et al., 2009). Deﬁciency of the Pxmp2 channel may disrupt
intracellular solute trafﬁc in vivo and, as a result, cause malfunctioning
of peroxisomal metabolic machinery.
As shown in this study, Pxmp2 / mice were unable to nurse
their pups due to retarded ductal outgrowth during puberty.
Immunohistochemical analysis revealed that Pxmp2 deletion
speciﬁcally suppresses the proliferation of epithelial cells. How-
ever, while the mammary glands were severely undeveloped, the
existing rudimentary epithelium was still able to respond to
pregnancy hormones and to undergo terminal differentiation.
Comprehensive tissue transplantation experiments showed that
mammary fat pad was the tissue responsible for impaired devel-
opment of the epithelium. We detected peroxisomes in stromal
adipocytes and showed that the fat pad of wild-type mice contains
Pxmp2, which was associated with peroxisomal membranes and
was functionally active as a channel-forming protein. These data
led us to suggest an involvement of fat pad Pxmp2 in the
regulation of mammary epithelial development.
Pxmp2 is a prominent component of mammalian peroxisomal
membranes in liver and kidney, and its malfunctioning or deletion
would predict severe consequences for peroxisomal function and
ultimately for the whole organism. However, except suppressed
mammary gland growth, only minor phenotypic changes of Pxmp2
knock-out mice were detected. The mild phenotype implies that the
peroxisomal membrane contains additional channel-forming proteins
with overlapping functions. Indeed, our previous studies have shown
the presence of several different channel-forming activities in mam-
malian and yeast peroxisomes (Antonenkov and Hiltunen, 2012). As
have been shown recently in our experiments, these channel-forming
activities are carried out by members of the Pex11 family of perox-
isomal membrane proteins (Manuscript in preparation). This is likely
to lead to functional redundancy of peroxisomal channels in most
tissues preventing evidentmalfunctioning of peroxisomes in Pxmp2 /
mice. The functional redundancy of several mammalian peroxiso-
mal proteins has been well documented (Baes and Van Veldhoven,
2012). A poor phenotype was observed when the knock-out mouse
models for multifunctional enzyme type 1 (Qi et al., 1999), α-
methylacyl-CoA racemase (Savolainen et al., 2004), and 3-oxoacyl-
CoA thiolase B (Chevillard et al., 2004) were analyzed.
A deﬁciency of the Pxmp2 channel has an effect on the
development of mammary epithelium through dysfunction of
mammary stroma, as shown by our transplantation experiments.
This observation adds to the list of instances where the stroma
inﬂuences epithelial outgrowth and differentiation. Different stro-
mal cells including ﬁbroblasts (Yang et al., 2006; Lanigan et al.,
2007), adipocytes (Landskroner-Eiger et al., 2010), macrophages
and eosinophils (Gouon-Evans et al., 2000) are required for proper
postnatal development of the mammary epithelium. Members of
the transforming growth factor beta (TGFβ) family – inhibins and
activins – were the ﬁrst signaling molecules shown to regulate
mammary epithelial outgrowth through stromal-epithelial inter-
action (Robinson and Hennighausen, 1997). An important regula-
tory axis is paracrine signaling triggered by estrogen and conveyed
by action of the epithelial ERα, amphiregulin and the stromal
epidermal growth factor receptor (Wiesen et al., 1999; Mallepell et
al., 2006; Sternlicht and Sunnarborg, 2008). Interestingly, a grow-
ing number of observations revealed tissue- and cell-speciﬁc
manifestations of the malfunctioning of peroxisomes and depen-
dence of the adjacent tissues on peroxisomal functions (Baes and
van Veldhoven, 2012). Thus, our ﬁndings on mammary glands
coincide with the reports on the role of glial peroxisomes in
maintaining the structural and functional integrity of neurons in
the central nervous system. Genetic inactivation of peroxisomes in
oligodendrocytes, which are the primary components of glia
(Kassmann et al., 2007), but not in neurons or astrocytes
(Bottelbergs et al., 2010) caused axonal degeneration and demye-
lination. It is important to note the similar role of these tissues: the
mammary fat pad provides vital trophic and regulatory assistance
to growing epithelium (Hovey and Aimo, 2010; McNally and
Martin, 2011), and glial cells serve the same functions for the
neuronal network (Kassmann et al., 2007). These observations
indicate that fat pad and glial peroxisomes apparently have much
in common in maintaining integrity of the mammary epithelium
and the neuronal axons, respectively.
Since peroxisomes are crucially involved in lipid metabolism,
one can predict that abnormalities in lipid homeostasis leading to
trophic and/or regulatory malfunctioning of mammary fat pad are
associated with an abnormal epithelial growth. Indeed, systemic
diet-induced perturbations in lipid composition (Flint et al., 2005;
Olson et al., 2010; Berryhill et al., 2012) as well as local deﬁciency of
mammary adipocytes (Hovey and Aimo, 2010; Landskroner-Eiger
et al., 2010) or separate lipid-metabolizing enzymes such as acyl-
CoA:diacylglycerol transferase 1 (Cases et al., 2004) result in
impaired mammary gland development. In addition to trophic
assistance, some lipids play an important role in regulatory net-
works as ligands for nuclear and other receptors. One example is an
involvement of peroxisome proliferator-activated receptors α and β
(PPAR’s) which use lipids as ligands (Schupp and Lazar, 2010), in the
regulation of mammary gland development. Although PPARα dis-
ruption is not associated with abnormal mammary growth (Lee et
al., 1995), activation of this receptor during puberty (manuscript in
preparation) and pregnancy (Yang et al., 2006) severely impairs
mammary epithelial development in mice. In contrast, activation of
PPARβ is accompanied by accelerated growth of mammary epithe-
lium (our unpublished observation). Interestingly, evaluation of
pertinent chromatin immunoprecipitation followed by deep
sequencing (ChIP-seq) data from the Gene Expression Omnibus
(GEO) repository (Yamaji et al., 2013; Lain et al., 2013; Kang et al.,
2014) revealed that STAT5 and progesterone receptor (PR) bind
strongly to promoter/enhancer regions of Pxmp2 gene. Both, STAT5
and PR are known as major controlling transcriptional factors
governing mammary gland development (Barash, 2006; Obr and
Edwards, 2012; Obr et al., 2013).
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According to our lipidomics data, the metabolism of fatty acids
is compromised in the Pxmp2-deﬁcient mammary fat pad. This is
evident from the signiﬁcant decrease in the content of myristic
acid that may indicate deﬁciency in the export of the β-oxidation
products from peroxisomes due to deletion of the Pxmp2 channel
(Antonenkov and Hiltunen, 2012). We also found a decreased
content of a set of diacylglycerols and phospholipids containing
mostly polyunsaturated fatty acids in the fat pad of Pxmp2 /
mice relative to wild-type animals. These results are in contrast to
those generally observed on other models of peroxisomal dis-
orders that display an elevation in the concentrations of very long-
chain fatty acids, branched chain fatty acids, and bile acid
precursors as well as a decrease in the content of plasmalogenes
(Baes and Van Veldhoven, 2012). These data were mostly collected
using models of generalized malfunctioning of peroxisomes.
However, mice deﬁcient in speciﬁc peroxisomal proteins fre-
quently show a phenotype with tissue preference including local
disturbances in lipid metabolism (Baes and Van Veldhoven, 2012,
Fransen et al., 2012). These later observations are in accordance
with the phenotype of Pxmp2 / mice since we did not ﬁnd any
abnormalities in lipid composition in the body ﬂuids but only in
the mammary fat pad of transgenic animals.
The mechanistic link between the Pxmp2-dependent lipid
metabolism in the mammary fat pad and the defective mammary
epithelial growth remains to be established. Our data did not
revealed the involvement of oxidative stress and lipid peroxidation
as factors connecting these processes. Instead, our observations
indicating that the Pxmp2 deﬁciency in mammary stroma affects
growth of epithelium point to the potential role of regulatory
factors involved in the cross-talk between these two compartments.
This coincides with our ﬁnding that Pxmp2 deﬁciency has an effect
on the expression pattern of peroxisomal proteins in mammary fat
pad. All these data indicate that in addition to a direct effect on lipid
metabolism, Pxmp2 deﬁciency may affect the regulatory pathways
coordinated by lipid-sensing proteins. This prediction is in accor-
dance with the data showing that deletion of peroxisomal multi-
functional protein 2 involved in β-oxidation resulted in coordinate
induction of PPARα and SREBP2 (Martens et al., 2008). Even mild
metabolic disturbances in stromal cells caused by Pxmp2 deletion
would affect mechanisms governing epithelial cell proliferation
through activation or suppression of different receptors or other
proteins by compounds produced in peroxisomes. For instance,
deﬁciency in myristic acid may delay myristoylation of proteins
involved in regulation of mammary epithelium development, such
as members of the Wnt-β-catenin pathway (Jarde and Dale, 2012;
Hu et al., 2010) while a decrease in the content of polyunsaturated
fatty acids in phospholipids would affect lipid composition of
biological membranes, which is an important factor in cell growth
and differentiation (Sampaio et al., 2011).
In conclusion, here we reveal that the peroxisomal membrane
channel protein, Pxmp2, is essential for the promotion of mam-
mary gland development in mice. We also describe the key role of
the mammary stroma in the Pxmp2-dependent epithelial growth
and ﬁnd that deletion of the Pxmp2 gene results in abnormal lipid
homeostasis in the mammary fat pad. The Pxmp2 / mouse
model represents a novel and useful tool for investigation of lipid
metabolism as well as lipid-sensitive signaling between mammary
fat pad and epithelium, which are of value in understanding
mechanisms of mammary gland development.
Acknowledgements
This work was supported by grants from the Academy of
Finland, Sigrid Juselius Foundation and Orion-Farmos Research
Foundation. The authors would like to thank Leena Ollitervo,
Remya R. Nair, and Daniela Mennerich for technical assistance
and members of ZORA biosciences staff: Kim Ekroos and Laura
Heiskanen for analysis of complex lipids.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.03.022.
References
Ahlemeyer, B., Gottwald, M., Baumgart-Vogt, E., 2012. Deletion of a single allele of
the Pex11β gene is sufﬁcient to cause oxidative stress, delayed differentiation
and neuronal death in mouse brain. Dis. Model. Mech. 5, 1–16.
Antonenkov, V.D., Hiltunen, J.K., 2012. Transfer of metabolites across the perox-
isomal membrane. Biochim. Biophys. Acta 1822, 1374–1386.
Antonenkov, V.D., Grunau, S., Ohlmeier, S., Hiltunen, J.K., 2010. Peroxisomes are
oxidative organelles. Antioxid. Redox Signal. 13, 525–537.
Antonenkov, V.D., Sormunen, R.T., Hiltunen, J.K., 2004. The behavior of peroxisomes
in vitro: mammalian peroxisomes are osmotically sensitive particles. Am. J.
Physiol. Cell Physiol. 287, C1623–C1635.
Baes, M., Van Veldhoven, P.P., 2012. Mouse models for peroxisome biogenesis
defects and β-oxidation enzyme deﬁciencies. Biochim. Biophys. Acta 1822,
1489–1500.
Barash, I., 2006. Stat5 in the mammary gland: controlling normal development and
cancer. J. Cell. Physiol. 209, 305–313.
Berryhill, G.E., Gloviczki, J.M., Trott, J.F., Aimo, L., Kraft, J., Cardiff, R.D., Paul, C.T.,
Petrie, W.K., Lock, A.L., Hovey, R.C., 2012. Diet-induced metabolic change
induces estrogen-independent allometric mammary growth. Proc. Nat. Acad.
Sci. U.S.A. 109, 16294–16299.
Bottelbergs, A., Verheijden, S., Hulshagen, L., Gutmann, D.H., Goebbels, S., Nave, K.-
A., Kassmann, C., Baes, M., 2010. Axonal integrity in the absence of functional
peroxisomes from projection neurons and astrocytes. Glia 58, 1532–1543.
Brisken, C, 2013. Progesteron signaling in breast cancer: a neglected hormone
coming into the limelight. Nat. Rev. Cancer 13, 385–396.
Brisken, C., Park, S., Vass, T., Lydon, J.P., O’Malley, B.W., Weinberg, R.A., 1998. A
paracrine role for the epithelial progesterone receptor in mammary gland
development. Proc. Nat. Acad. Sci. U.S.A. 95, 5076–5081.
Cases, S., Zhou, P., Shillingford, J.M., Wiseman, B.S., Fish, J.D., Angle, C.S., Hennin-
ghausen, L., Werb, Z., Farese, R.V., 2004. Development of the mammary gland
requires DGAT1 expression in stromal and epithelial tissues. Development 131,
3047–3055.
Ciarloni, L., Mallepell, S., Brisken, C., 2007. Amphiregulin is an essential mediator of
estrogen receptor alpha function in mammary gland development. Proc. Nat.
Acad. Sci. U.S.A. 104, 5455–5460.
Chevillard, G., Clemencet, M.C., Latruffe, N., Nicolas-Frances, V., 2004. Targeted
disruption of the peroxisomal thiolase B gene in mouse: a new model to study
disorders related to peroxisomal metabolism. Biochemie 86, 849–856.
Cohen, P.E., Zhu, L., Nishimura, K., Pollard, J.W., 2002. Colony-stimulating factor
1 regulation of neuroendocrine pathways that control gonadal function in mice.
Endocrinology 143, 1413–1422.
Ekroos, K., 2008. Unraveling glycerophospholipidomes by lipidomics. In: Wan, F.
(Ed.), In: Biomarker Methods in Drug Discovery and Development, (Ed.)
Humana Press, pp. 369–384.
Ekroos, K., Ejsing, C.S., Bahr, U., Karas, M., Simons, K., Shevchenko, A., 2003.
Charting molecular composition of phosphatidylcholines by fatty acid scanning
and ion trap MS3 fragmentation. J. Lipid Res. 44, 2181–2192.
Fernandes, C.G., Leipnitz, G., Seminotti, B., Amaral, A.U., Zanatta, A., Vargas, C.R.,
Dutra Filho, D.S., Wajner, M., 2010. Experimental evidence that phenylalanine
provokes oxidative stress in hippocampus and cerebral cortex of developing
rats. Cell. Mol. Neurobiol. 30, 317–326.
Flint, D.J., Travers, M.T., Barber, M.C., Binart, N., Kelly, P.A., 2005. Diet-induced
obesity impairs mammary development and lactogenesis in murine mammary
gland. Am. J. Physiol. 288, 1179–1187.
Fransen, M., Nordgren, M., Bo, W., Apanasets, O., 2012. Role of peroxisomes in ROS/
RNS-metabolism: implications for human disease. Biochim. Biophys. Acta 1822,
1363–1373.
Gouon-Evans, V., Rothenberg, M.E., Pollard, J.W., 2000. Postnatal mammary gland
development requires macrophages and eosinophils. Development 127,
2269–2282.
Hand, A.R., 1973. Morphologic and cytochemical identiﬁcation of peroxisomes in
the rat parotid and other exocrine glands. J. Histochem. Cytochem. 21, 131–141.
Hovey, R.C., Aimo, L., 2010. Diverse and active roles for adipocytes during mammary
gland growth and function. J. Mammary Gland Biol. Neoplasia 15, 279–290.
Howlin, J., McBryan, J., Martin, F., 2006. Pubertal mammary gland development:
insights from mouse models. J. Mammary Gland Biol. Neoplasia 11, 283–297.
Hu, T., Li, C., Cao, Z., Van Raay, T.J., Smith, J.G., Willert, K., Solnica-Krezel, L., Coffey, R.
J., 2010. Myristoylated Naked2 antagonized Wnt-β-catenin activity by degrad-
ing disheveled-1 at the plasma membrane. J. Biol. Chem. 285, 13561–13568.
Jarde, T., Dale, T., 2012. Wnt signaling in murine postnatal mammary gland
development. Acta Physiol. 204, 118–127.
M.H. Vapola et al. / Developmental Biology 391 (2014) 66–80 79
Jung, H.R., Sylvanne, T., Koistinen, K.M., Tarasov, K., Kauhanen, K.M., Ekroos, K.,
2011. High throughput quantitative molecular lipidomics. Biochim. Biophys.
Acta 1811, 925–934.
Kang, K., Yamaji, D., Yoo, K.H., Robinson, G.W., Hennighausen, L., 2014. Mammary-
speciﬁc gene activation of Stat5 during pregnancy and the establishment of
H3K4me3 marks. Mol. Cell. Biol. 34, 464–473.
Kassmann, C.M., Lappe-Siefke, C., Baes, M., Brugger, B., Mildner, A., Werner, H.B.,
Natt, O., Michaels, T., Prinz, M., Frahm, J., Nave, K.-A., 2007. Axonal loss and
neuroinﬂammation caused by peroxisome-deﬁcient oligodendrocytes. Nat.
Genet. 39, 969–976.
Lain, A.R., Creighton, C.J., Conneely, O.M., 2013. Research resource: progesterone
receptor targetome underlying mammary gland branching morphogenesis.
Mol. Endocrinol. 27, 1743–1761.
Landskroner-Eiger, S., Park, J., Israel, D., Pollard, J.W., Scherer, P.E., 2010. Morpho-
genesis of the developing mammary gland: stage-dependent impact of adipo-
cytes. Dev. Biol. 344, 968–978.
Lanigan, F., O’Connor, D., Martin, F., Gallagher, W.M., 2007. Molecular links between
mammary gland development and breast cancer. Cell. Mol. Life Sci. 64,
3159–3184.
Lee, S.S., Pineau, T., Drago, J., Lee, E.G., Owens, J.W., Kroetz, D.L., Fernandez-Salguero,
P.M., Westphal, H., Gonzales, F.G., 1995. Targeted disruption of the alpha
isoform of the peroxisome proliferator-activated receptor gene in mice results
in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell.
Biol. 15, 3012–3022.
Lopez-Erauskin, L., Fourcade, S., Galino, J., Ruiz, M., Schluter, A., Naudi, A., Jove, M.,
Portero-Otin, M., Pamplona, R, Ferrer, I., Pujol, A., 2011. Antoxidants halt axonal
degeneration in a mouse model of X-adrenoleukodystrophy. Ann. Neurol. 70,
84–92.
Mallepell, S., Krust, A., Chambon, P., Brisken, C., 2006. Paracrine signaling through
the epithelial estrogen receptor α is required for proliferation and morphogen-
esis in the mammary gland. Proc. Nat. Acad. Sci. U.S.A. 103, 2196–2201.
Martens, K., Ver Loren van Themaat, E., van Batenburg, M.F., Heinäniemi, M.,
Huyghe, S., Van Hummelen, P., Calberg, C., Van Veldhoven, P.P., Van Kampen, A.,
Baes, M., 2008. Coordinate induction of PPARα and SREBP2 in multifunctional
protein 2 deﬁcient mice. Biochim. Biophys. Acta 1781, 694–702.
McCready, J., Arendt, L.M., Rudnick, J.A., Kuperwasser, C., 2010. The contribution of
dynamic stromal remodeling during mammary development to breast carci-
nogenesis. Breast Cancer Res. 12, 205–214.
McNally, S., Martin, F., 2011. Molecular regulators of pubertal mammary gland
development. Ann. Med. 43, 212–234.
Moinard, C., Cynober, L., de Bandt, J.P., 2005. Polyamines: metabolism and
implications in human diseases. Clin. Nutr. 24, 184–197.
Neville, M.C., McFadden, T.B., Forsyth, I., 2002. Hormonal regulation of mammary
differentiation and milk secretion. J. Mammary Gland Biol. Neoplasia 7, 49–66.
Obr, A.E., Edwards, D.P., 2012. The biology of progesterone receptor in the normal
mammary gland and in breast cancer. Mol. Cell. Endocrinol. 357, 4–17.
Obr, A.E., Grimm, S.L., Bishop, K.A., Pike, J.W., Lydon, J.P., Edwards, D.P., 2013.
Progesterone receptor and Stat5 signalling cross talk through RANKL in
mammary epithelial cells. Mol. Endocrinol. 27, 1808–1824.
Olson, L.K., Tan, Y., Zhao, Y., Aupperlee, M.D., Haslam, S.Z., 2010. Pubertal exposure
of high fat diet causes mouse strain-dependent alterations in mammary gland
development and estrogen responsiveness. Int. J. Obes. 34, 1415–1426.
Pirinen, E., Kuulasmaa, T., Pietilä, M., Heikkinen, S., Tusa, M., Itkonen, P., Boman, S.,
Skommer, J., Virkamäki, A., Hohtola, E., Kettunen, M., Fatrai, S., Kansanen, E.,
2007. Enhanced polyamine catabolism alters homeostatic control of white
adipose tissue mass, energy expenditure, and glucose metabolism. Mol. Cell.
Biol. 27, 4953–4967.
Qi, C., Zhu., Y., Pan., J., Usuda, N., Maeda, N., Yeldandi, A.V., Rao, M.S., Hashimoto, T.,
Reddy, J.K., 1999. Absence of spontaneous peroxisome proliferation in enoyl-
CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deﬁcient mouse liver. J.
Biol. Chem. 274, 15775–15780.
Reddy, J.K., Hashimoto, T., 2001. Peroxisomal β-oxidation and peroxisome prolif-
erator activated receptor α: an adaptive metabolic system. Annu. Rev. Nutr. 21,
193–230.
Robinson, G.W., Hennighausen, L., 1997. Inhibins and activins regulate mammary
epithelial cell differentiation through mesenchymal-epithelial interactions.
Development 124, 2701–2708.
Rokka., A., Antonenkov, V.D., Soininen, R., Immonen, H.L., Pirilä, P.L., Bergmann, U.,
Sormunen, R.T., Weckstrom̈, M., Benz, R., Hiltunen, J.K., 2009. Pxmp2 is a
channel-forming protein in mammalian peroxisomal membrane. PLoS One 4,
e5090.
Sampaio, J.L., Gerl, M.J., Klose, C., Ejsing, C.S., Beug, H., Simons, K., Shevchenko, A.,
2011. Proc. Nat. Acad. Sci 108, 1903–1907.
Savolainen, K., Kotti, T.J., Schmitz, W., Savolainen, T.I., Sormunen, R.T., Ilves, M.,
Vainio, S.J., Conzelmann, E., Hiltunen, J.K., 2004. A mouse model for alpha-
methylacyl-CoA racemase deﬁciency: adjustment of bile acid synthesis and
intolerance to dietary methyl-branched lipids. Hum. Mol. Gen. 13, 955–965.
Schupp, M., Lazar, M.A., 2010. Endogenous ligands for nuclear receptors: digging
deeper. J. Biol. Chem. 285, 40409–40415.
Singh, I., Pujol, A., 2010. Pathomechanisms underlying X-adrenoleukodystrophy: a
three-hit hypothesis. Brain Pathol. 20, 838–844.
Sternlicht, M.D., Sunnarborg, S.W., 2008. The ADAM17-amphiregulin-EGFR axis in
mammary development and cancer. J. Mammary Gland Biol. Neoplasia 13,
181–194.
Tyurina, Y.Y., Tyurin, V.A., Epperly, M.W., Greenberger, J.S., Kagan, 2008. Oxidative
lipidomics of γ-irradiation-induced intestinal injury. Free Radical Biol. Med. 44,
299–314.
Wanders, R.J., Waterham, H.R., 2006. Biochemistry of mammalian peroxisomes
revisited. Annu. Rev. Biochem. 75, 295–332.
Wiesen, J.F., Young, P., Werb, Z., Cunha, G.R., 1999. Signaling through the stromal
epidermal growth factor receptor is necessary for mammary ductal develop-
ment. Development 126, 335–344.
Wu, T., Yankovskaya, V., McIntire, W.S., 2003. Cloning, sequencing, and hetero-
logous expression of the murine peroxisomal ﬂavoprotein, N1-acetylated
polyamine oxidase. J. Biol. Chem. 278, 20514–20525.
Yamaji, D., Kang, K., Robinson, G.W., Hennighausen, L., 2013. Sequential activation
of genetic programs in mouse mammary epithelium during pregnancy depends
on STAT5A/B concentration. Nucleic Acids Res. 41, 1622–1636.
Yang, Q., Kurotani, R., Yamada, A., Kimura, S., Gonzalez, F.G., 2006. Peroxisome
proliferator – activated receptor α activation during pregnancy severely impairs
mammary lobuloalveolar development in mice. Endocrinology 147, 4772–4780.
M.H. Vapola et al. / Developmental Biology 391 (2014) 66–8080
